LEXX
$0.71
Lexaria Bioscience
$.05
7.94%
LEXX
Earnings Whisper ®
N/A
3rd Quarter May 2026
Consensus:  ($0.09)
Revenue:  $0.10 Mil
Monday
Jul 13
0:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when LEXX reports earnings?
Beat
Meet
Miss

Where is LEXX's stock price going from here?
Up
Flat
Down
Stock chart of LEXX
Analysts
Summary of analysts' recommendations for LEXX
Score
Grade
Pivots
Resistance
$0.83
$0.78
$0.74

$0.69

Support
$0.66
$0.61
$0.57
Tweet
Growth
Description
Lexaria Bioscience Corp. provides drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. Lexaria Bioscience Corp. is based in Kelowna, Canada.